心脏外科出血、输血与质量指标:ERAS心脏学会与患者血液管理促进会联合共识
该联合共识由国际专家小组基于近10年文献并采用改良RAND德尔菲法制定,围绕心脏外科出血控制、输血管理及质量指标形成30条共识声明,涵盖出血控制优先、关胸前核查表、再探查时间等质量指标、过度出血统一定义、抗纤溶药使用、抗血栓药停用及术前风险评分等。
要点
- 优先及时控制和管理出血对改善心脏外科患者结局至关重要。
- 需要比再探查率更全面的心脏外科出血质量指标,如再探查时间。
- 共识支持使用抗纤溶药、优化抗血栓药停用及术前风险评分识别高危患者。
核心结论
- 优先及时控制和管理出血对改善心脏外科患者结局至关重要。
- 需要比再探查率更全面的心脏外科出血质量指标。
- 实施增强质量指标的多学科质量改进可能改善患者照护和结局。
研究设计与样本
- 国际专家小组审查近10年相关文献,采用改良RAND德尔菲法达成共识。
主要发现
- 专家小组在8个类别中制定了30条共识声明。
- 共识涵盖优先控制出血、关胸前核查表以及再探查率之外的质量指标(如再探查时间)。
- 共识还涉及过度出血的统一定义、抗纤溶药使用、抗血栓药 optimal 停用及基于患者和手术因素的术前风险评分。
- 共识认为需要基于失血量与速度的客观出血量表,并配合粘弹性管理算法和标准化、以患者为中心的血液管理策略。
关键数值与推荐
- 共形成30条共识声明,分属8个类别。
- 推荐质量指标包括再探查时间等,而不仅限于再探查率。
- 推荐使用抗纤溶药。
- 推荐优化抗血栓药停用。
- 推荐基于患者和手术因素的术前风险评分以识别过度出血高危患者。
临床怎么用
- 心脏外科应优先及时控制和管理出血。
- 采用关胸前核查表以辅助出血控制。
- 使用抗纤溶药、优化抗血栓药停用,并基于术前风险评分识别高危患者。
- 应用基于失血量和速度的客观出血量表及粘弹性管理算法。
- 实施标准化、以患者为中心的血液管理策略和多学科质量改进举措。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Excessive perioperative bleeding is associated with major complications in cardiac surgery, resulting in increased morbidity, mortality, and cost. METHODS: An international expert panel was convened to develop consensus statements on the control of bleeding and management of transfusion and to suggest key quality metrics for cardiac surgical bleeding. The panel reviewed relevant literature from the previous 10 years and used a modified RAND Delphi methodology to achieve consensus. RESULTS: The panel developed 30 consensus statements in 8 categories, including prioritizing control of bleeding, prechest closure checklists, and the need for additional quality indicators beyond reexploration rate, such as time to reexploration. Consensus was also reached on the need for a universal definition of excessive bleeding, the use of antifibrinolytics, optimal cessation of antithrombotic agents, and preoperative risk scoring based on patient and procedural factors to identify those at greatest risk of excessive bleeding. Furthermore, an objective bleeding scale is needed based on the volume and rapidity of blood loss accompanied by viscoelastic management algorithms and standardized, patient-centered blood management strategies reflecting an interdisciplinary approach to quality improvement. CONCLUSIONS: Prioritizing the timely control and management of bleeding is essential to improving patient outcomes in cardiac surgery. To this end, a cardiac surgical bleeding quality metric that is more comprehensive than reexploration rate alone is needed. Similarly, interdisciplinary quality initiatives that seek to implement enhanced quality indicators will likely lead to improved patient care and outcomes.
引用
- Salenger R, Arora RC, Bracey A, et al. Cardiac Surgical Bleeding, Transfusion, and Quality Metrics: Joint Consensus Statement by the Enhanced Recovery After Surgery Cardiac Society and Society for the Advancement of Patient Blood Management. Ann Thorac Surg. 2024. PMID: 39222899. doi:10.1016/j.athoracsur.2024.06.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。